Funtleyder Leslie D.'s Form 4 filing
Applied Therapeutics, Inc. (APLT) · filed Mar 6, 2025
- Accession no.
- 0000950170-25-035041
- Filed
- Mar 6, 2025, 8:30 PM ET
- Trade date
- Mar 4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $6.38K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Funtleyder Leslie D.CIK 0001775394 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | SSaleDisposed | −14,502 | $0.44 | −$6,380.88 | 390,459 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Interim Chief Executive Officer and Chief Financial Officer